The Use of Legume Seed for Expression and Storage of High Value Proteins

June 2014
Czech Journal of Genetics & Plant Breeding;2014, Vol. 50 Issue 2, p69
Academic Journal
There is an ever growing need for the use of recombinant proteins both in medicine and industry; however their widespread use is limited by the lack of production capacity. Transgenic plants offer the possibility to produce and deliver recombinant proteins on a large scale with low production costs and with minimal purification or enrichment requirements. Among crop plants, legumes have great potential as a protein production platform because of their naturally high protein content, nutritional value, independence of N-nutrition, pollen containment, available processing technology, storage stability etc. There have been several proof-of-principle attempts to produce large amounts of recombinant protein in seed of both soybean and pea, however, our knowledge of processes regulating the foreign protein production and deposition is still limited.


Related Articles

  • State of research in the field of the creation of plant vaccines for veterinary use. Permyakova, N.; Uvarova, E.; Deineko, E. // Russian Journal of Plant Physiology;Jan2015, Vol. 62 Issue 1, p23 

    Transgenic plants as an alternative of costly systems of recombinant immunogenic protein expression are the source for the production of cheap and highly efficient biotherapeuticals of new generation, including plant vaccines. In the present review, possibilities of plant system application for...

  • Efficient Secretion of Recombinant Proteins from Rice Suspension-Cultured Cells Modulated by the Choice of Signal Peptide. Huang, Li-Fen; Tan, Chia-Chun; Yeh, Ju-Fang; Liu, Hsin-Yi; Liu, Yu-Kuo; Ho, Shin-Lon; Lu, Chung-An // PLoS ONE;10/16/2015, Vol. 10 Issue 10, p1 

    Plant-based expression systems have emerged as a competitive platform in the large-scale production of recombinant proteins. By adding a signal peptide, αAmy3sp, the desired recombinant proteins can be secreted outside transgenic rice cells, making them easy to harvest. In this work, to...

  • N-Glycosylation of Recombinant Therapeutic Glycoproteins in Plant Systems. Balen, Biljana; Krsnik-Rasol, Marijana // Food Technology & Biotechnology;Jan-Mar2007, Vol. 45 Issue 1, p1 

    Transgenic plants have recently emerged as a promising system for low-cost and large-scale production of therapeutic proteins. Despite many advantages plants offer as hosts for expression of recombinant proteins, there are certain limitations caused by major structural differences between plant...

  • A Cost-Effective ELP-Intein Coupling System for Recombinant Protein Purification from Plant Production Platform. Tian, Li; Sun, Samuel S. M. // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    Background: Plant bioreactor offers an efficient and economical system for large-scale production of recombinant proteins. However, high cost and difficulty in scaling-up of downstream purification of the target protein, particularly the common involvement of affinity chromatography and protease...

  • Single-Step Purification and Characterization of A Recombinant Serine Proteinase Inhibitor from Transgenic Plants. Jha, Shweta; Agarwal, Saurabh; Sanyal, Indraneel; Amla, D. // Applied Biochemistry & Biotechnology;May2016, Vol. 179 Issue 2, p220 

    Expression of recombinant therapeutic proteins in transgenic plants has a tremendous impact on safe and economical production of biomolecules for biopharmaceutical industry. The major limitation in their production is downstream processing of recombinant protein to obtain higher yield and purity...

  • Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Tackaberry, Eilleen S.; Prior, Fiona; Bell, Margaret; Tocchi, Monika; Porter, Suzanne; Mehnic, Jelica; Ganz, Peter R.; Sardana, Ravinder; Altosaar, Illimar; Dudani, Anil // Genome;Jun2003, Vol. 46 Issue 3, p521 

    The use of transgenic plants in the production of recombinant proteins for human therapy, including subunit vaccines, is being investigated to evaluate the efficacy and safety of these emerging biopharmaceutical products. We have previously shown that synthesis of recombinant glycoprotein B (gB)...

  • Production of recombinant proteins in plant root exudates. Borisjuk, Nikolai V.; Borisjuk, Ludmyla G.; Logendra, Sithes; Petersen, Frank; Gleba, Yuri; Raskin, Ilya // Nature Biotechnology;May99, Vol. 17 Issue 5, p466 

    The large-scale production of recombinant proteins in plants is limited by relatively low yields and difficulties in extraction and purification. These problems were addressed by engineering tobacco plants to continuously secrete recombinant proteins from their roots into a simple hydroponic...

  • Molecular farming of recombinant antibodies in plants. Schillberg, S.; Fischer, R.; Emans, N. // Cellular & Molecular Life Sciences;Mar2003, Vol. 60 Issue 3, p433 

    : Antibodies represent a large proportion of therapeutic drugs currently in development. In most cases, they are produced in mammalian cell lines or transgenic animals because these have been shown to fold and assemble the proteins correctly and generate authentic glycosylation patterns....

  • Plastoglobules: a new address for targeting recombinant proteins in the chloroplast. Vidi, Pierre-Alexandre; Kessler, Felix; Brehelin, Claire // BMC Biotechnology;2007, Vol. 7, p4 

    Background: The potential of transgenic plants for cost-effective production of pharmaceutical molecules is now becoming apparent. Plants have the advantage over established fermentation systems (bacterial, yeast or animal cell cultures) to circumvent the risk of pathogen contamination, to be...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics